#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune-mediated myasthenia gravis Hereditary ataxia Cholangiosarcoma Hereditary motor and sensory neuropathy Cholangitis sclerosing Desmoid tumour Immune-mediated enterocolitis Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Leukodystrophy Waldenstrom's macroglobulinaemia refractory Antisynthetase syndrome Phaeochromocytoma Haemophilia Transitional cell carcinoma Loeys-Dietz syndrome More trials…

    Learn about Rare Diseases

    Andersen-Tawil syndrome – Treatment Propionic acidaemia – Treatment Primary immunodeficiency syndrome – Basic Information Rosai-Dorfman syndrome Optic glioma – Treatment Loeys-Dietz syndrome – Basic Information Proteus syndrome – Life with Disease Focal segmental glomerulosclerosis – Basic Information Primary mediastinal large B-cell lymphoma – Basic Information Short-bowel syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ruzasvir Tobevibart Metamizole Aminocaproic Acid Munc-Cd34 Gskvx000000014593 Dexamethasone Base LY3841136 SODIUM Thymalfasin Cinnarizine Tezacaftor Xtmab-16 Ucart20X22 Minoxidil Ocrelizumab Sodium Acetate (1-13C) Posaconazole OMECAMTIV MECARBIL Fenfluramine Hydrochloride Tusamitamab Ravtansine More therapies…

    Learn about Your Condition

    Organ donor Diabetic autonomic neuropathy Thalassaemia alpha Coronary artery dissection Arteriospasm coronary Colorectal cancer metastatic Thrombocytopenia Lymphocytic leukaemia Cutaneous sarcoidosis Rheumatoid arthritis Liposarcoma metastatic Follicular thyroid cancer Angina pectoris Neonatal asphyxia Endometrial stromal sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Biliary neoplasm

  • Study of AZD4360 safety and effectiveness in adults with advanced solid tumors including gastric, gastroesophageal junction, biliary tract cancer and pancreatic cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Adenocarcinoma pancreas
    • Gastric cancer
    Investigated Drugs:
    • AZD4360
    Germany

  • Study on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Biliary cancer metastatic
    • Biliary neoplasm
    Investigated Drugs:
    • Tegafur
    • Glucose
    • Rilvegostomig
    Belgium Denmark France Germany Italy Norway +2

  • Study on BI 907828 for Patients with Advanced Biliary Tract, Pancreatic, Lung, or Bladder Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Lung adenocarcinoma
    • Pancreatic carcinoma
    Investigated Drugs:
    • (3S,3’S,3A’s,10A’s)-6-Chloro-3′-(3-Chloro-2-Fluorophenyl)-1′-(Cyclopropylmethyl)-6′-Methyl-2-Oxo-1,2,3′,3A’,10′,10A’-Hexahydro-1’H-Spiro[Indole-3,2′-Pyrrolo[2′,3′:4,5]Pyrrolo[1,2-B]Indazole]-7′-Carboxylic Acid
    Austria Belgium France Germany Spain

  • Study of pembrolizumab with gemcitabine and cisplatin as first treatment for patients with advanced or inoperable bile duct cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Biliary neoplasm
    Investigated Drugs:
    • Gemcitabine
    • Cisplatin
    • Pembrolizumab
    Belgium France Germany Ireland Italy The Netherlands +1
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!